Reneo Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Reneo Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Reneo Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Reneo Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $26k | 16k | 1.60 |
| 2023-09-30 | $219k | 29k | 7.62 |
| 2023-06-30 | $417k | 64k | 6.56 |
| 2023-03-31 | $317k | 53k | 5.98 |
| 2022-12-31 | $134k | 58k | 2.33 |
| 2022-09-30 | $195k | 58k | 3.38 |
| 2022-06-30 | $145k | 55k | 2.66 |
| 2022-03-31 | $3.0k | 1.1k | 2.81 |
| 2021-12-31 | $23k | 2.7k | 8.64 |